Track topics on Twitter Track topics that are important to you
Teva Pharmaceutical Industries Ltd. is teetering on the edge of a junk rating amid its biggest bond sell-off on record. Moody's Investors Service downgraded the drugmaker's debt to one step above junk on Thursday and warned that the company's ratings may be pressured lower over the next 12 to 18 months.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...